ROBIN CAMPBELL: Open Payments
NPI 1689066151 · TYLERTOWN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,277 in 46 payments from 13 companies in 2025. Trend: 2023 $2,221 · 2024 $219 · 2025 $2,277
Travel & lodging: $1,151Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 21 | $1,599 |
| Insulet Corporation | 6 | $220 |
| Novo Nordisk Inc | 4 | $164 |
| Lilly USA, LLC | 3 | $61 |
| Amgen Inc. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| RGH Enterprises LLC | 1 | $30 |
| Gilead Sciences, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
Products named: MINIMED 780G, Omnipod, Wegovy, MOUNJARO, GVOKE HYPOPEN, Ozempic, JARDIANCE, Trodelvy.
Industry payments across MS — which companies pay providers there.
